Bardhan K - Search Results

1

Wang Q, Bardhan K, Boussiotis VA, Patsoukis N. Wang Q, et al. Among authors: bardhan k. Adv Biol (Weinh). 2021 Sep;5(9):e2100758. doi: 10.1002/adbi.202100758. Epub 2021 Jun 25. Adv Biol (Weinh). 2021. PMID: 34170628 Free PMC article. Review.

2

PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation.

Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B, Bell LN, Karoly ED, Freeman GJ, Petkova V, Seth P, Li L, Boussiotis VA. Patsoukis N, et al. Among authors: bardhan k. Nat Commun. 2015 Mar 26;6:6692. doi: 10.1038/ncomms7692. Nat Commun. 2015. PMID: 25809635 Free PMC article.

3

Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells.

Bardhan K, Aksoylar HI, Le Bourgeois T, Strauss L, Weaver JD, Delcuze B, Charest A, Patsoukis N, Boussiotis VA. Bardhan K, et al. Sci Rep. 2019 Nov 21;9(1):17252. doi: 10.1038/s41598-019-53463-0. Sci Rep. 2019. PMID: 31754127 Free PMC article.

4

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation.

Bardhan K, Anagnostou T, Boussiotis VA. Bardhan K, et al. Front Immunol. 2016 Dec 12;7:550. doi: 10.3389/fimmu.2016.00550. eCollection 2016. Front Immunol. 2016. PMID: 28018338 Free PMC article. Review.

5

Clinical significance of T cell metabolic reprogramming in cancer.

Herbel C, Patsoukis N, Bardhan K, Seth P, Weaver JD, Boussiotis VA. Herbel C, et al. Among authors: bardhan k. Clin Transl Med. 2016 Dec;5(1):29. doi: 10.1186/s40169-016-0110-9. Epub 2016 Aug 10. Clin Transl Med. 2016. PMID: 27510264 Free PMC article. Review.

6

Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.

Christofides A, Karantanos T, Bardhan K, Boussiotis VA. Christofides A, et al. Among authors: bardhan k. Oncotarget. 2016 Dec 20;7(51):85624-85640. doi: 10.18632/oncotarget.12928. Oncotarget. 2016. PMID: 27793053 Free PMC article. Review.

7

The adaptor molecule RIAM integrates signaling events critical for integrin-mediated control of immune function and cancer progression.

Patsoukis N, Bardhan K, Weaver JD, Sari D, Torres-Gomez A, Li L, Strauss L, Lafuente EM, Boussiotis VA. Patsoukis N, et al. Among authors: bardhan k. Sci Signal. 2017 Aug 22;10(493):eaam8298. doi: 10.1126/scisignal.aam8298. Sci Signal. 2017. PMID: 28831022 Review.

8

Publisher Correction: Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells.

Bardhan K, Aksoylar HI, Le Bourgeois T, Strauss L, Weaver JD, Delcuze B, Charest A, Patsoukis N, Boussiotis VA. Bardhan K, et al. Sci Rep. 2020 Sep 23;10(1):15905. doi: 10.1038/s41598-020-71090-y. Sci Rep. 2020. PMID: 32963251 Free PMC article.

9

Corrigendum: Regulation of T Cell Differentiation and Function by EZH2.

Karantanos T, Christofides A, Bardhan K, Li L, Boussiotis VA. Karantanos T, et al. Among authors: bardhan k. Front Immunol. 2016 Sep 14;7:346. doi: 10.3389/fimmu.2016.00346. eCollection 2016. Front Immunol. 2016. PMID: 27648006 Free PMC article.

10

The role of metabolic reprogramming in T cell fate and function.

Patsoukis N, Bardhan K, Weaver J, Herbel C, Seth P, Li L, Boussiotis VA. Patsoukis N, et al. Among authors: bardhan k. Curr Trends Immunol. 2016;17:1-12. Curr Trends Immunol. 2016. PMID: 28356677 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters